- Home
- VERA vs ASTH Comparison
VERA vs ASTH Comparison
Compare VERA & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- ASTH
- Stock Information
- Founded
- VERA 2016
- ASTH 1994
- Country
- VERA United States
- ASTH United States
- Employees
- VERA N/A
- ASTH N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- VERA Health Care
- ASTH Consumer Discretionary
- Exchange
- VERA Nasdaq
- ASTH Nasdaq
- Market Cap
- VERA 2.5B
- ASTH 2.2B
- IPO Year
- VERA 2021
- ASTH N/A
- Fundamental
- Price
- VERA $42.01
- ASTH $55.47
- Analyst Decision
- VERA Strong Buy
- ASTH Strong Buy
- Analyst Count
- VERA 9
- ASTH 6
- Target Price
- VERA $53.56
- ASTH $64.40
- AVG Volume (30 Days)
- VERA 683.6K
- ASTH 269.1K
- Earning Date
- VERA 11-07-2024
- ASTH 11-07-2024
- Dividend Yield
- VERA N/A
- ASTH N/A
- EPS Growth
- VERA N/A
- ASTH 45.24
- EPS
- VERA N/A
- ASTH 1.44
- Revenue
- VERA N/A
- ASTH $1,591,829,000.00
- Revenue This Year
- VERA N/A
- ASTH $33.99
- Revenue Next Year
- VERA N/A
- ASTH $24.43
- P/E Ratio
- VERA N/A
- ASTH $38.79
- Revenue Growth
- VERA N/A
- ASTH 22.76
- 52 Week Low
- VERA $9.68
- ASTH $28.87
- 52 Week High
- VERA $50.78
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- VERA 52.57
- ASTH 47.69
- Support Level
- VERA $39.22
- ASTH $54.81
- Resistance Level
- VERA $50.00
- ASTH $57.09
- Average True Range (ATR)
- VERA 2.41
- ASTH 1.75
- MACD
- VERA 0.24
- ASTH -0.71
- Stochastic Oscillator
- VERA 28.53
- ASTH 22.13
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.